About the Speakers

McKaye Black

McKaye Black, M.B.A.
Senior Business Design Strategist
C1 Innovation Lab

McKaye Black serves as the Senior Business Design Strategist for the C1 Innovation Lab, where she is responsible for identifying and supporting the innovation needs of the members of the Blue Cross and Blue Shield of Illinois, Texas, New Mexico, Oklahoma, and Montana plans.

Prior to this role, McKaye served as a design and innovation strategist for companies from start-ups to Fortune 100 corporations, in a variety of industries, identify fuel for growth by unearthing meaningful insights, creating experiences that people love, and developing winning strategies.

McKaye is a graduate of the MMM Program at Northwestern University, holding an MBA from the Kellogg School of Management and a MS of Design Innovation from the Segal Design Institute, and holds a bachelor’s degree in Chemical Engineering from Brigham Young University.

Amy Bucher, Ph.D.

Amy Bucher, Ph.D.
Chief Behavioral Officer

Amy Bucher, Ph.D., is Chief Behavioral Officer at Lirio, where she leads a team of behavioral scientists and health experts focused on designing AI-powered behavior change journeys to drive better personal and population health. She brings over 15 years of experience in digital health product design and research coupled with deep behavioral science training. Amy is a recognized expert on applying the psychology of motivation to design, and authored Engaged: Designing for Behavior Change published by Rosenfeld Media and named one of Kirkus’ favorite indie books of 2020. Prior to joining Lirio, Amy was Vice President of Behavior Change Design at Mad*Pow, a strategic design consultancy. Amy also served as Senior Manager of Specialty Pharmacy Strategy for the CVS Health Digital Innovation Lab, and as Associate Director of Behavior Science for the Johnson & Johnson Health and Wellness Solutions Group. Amy earned her PhD and MA in Organizational Psychology from the University of Michigan at Ann Arbor, and her AB magna cum laude in Psychology from Harvard University.

Linda M. Collins, Ph.D.

Linda M. Collins, Ph.D.
Professor, Social and Behavioral Sciences
School of Global Public Health
New York University

Dr. Collins’s interests are focused on development, dissemination, and application of the multiphase optimization strategy (MOST), an innovative methodological framework for optimizing and evaluating interventions in public health, education, criminal justice, and many other fields. MOST integrates ideas from engineering, behavioral science, multivariate statistics, health economics, and decision analysis. The objective of MOST is to improve intervention effectiveness, affordability, scalability, and efficiency, balancing these strategically to achieve intervention EASE. Dr. Collins has collaborated on research applying MOST in a range of areas, including HIV, smoking cessation, prevention of excessive alcohol use in college students, and weight loss. She is also collaborating on development of methods for decision-making based on the results of an optimization trial; optimizing interventions for cost-effectiveness; and optimizing adaptive interventions. Her research has been funded by the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Science Foundation. Dr. Collins’s publications have appeared in journals in the behavioral sciences, quantitative methodology, medicine, and engineering. She has given more than 100 invited presentations on MOST worldwide. Among the honors she has received are a Fulbright Specialist grant, the President’s Award from the Society for Prevention Research, and the 2020 Valkhov Chair from Radboud University Medical Centre in The Netherlands.

Linda A. Dimeff, Ph.D.

Linda A. Dimeff, Ph.D.
Chief Scientific Officer
Jaspr Health, Inc.

Linda A. Dimeff, Ph.D., is Chief Scientific Officer at Evidence-Based Practice Institute, Inc., dba Jaspr Health. She is also Institute Director at Portland DBT Institute, Inc. and Adjunct Clinical Faculty in the Department of Psychology at the University of Washington. Dr. Dimeff has devoted her career to building and clinically testing digital technologies to help people suffering from behavioral health problems receive evidence-based digital behavioral care. Her most recent NIH-funded studies focus specifically on suicide prevention. With funding from NIMH, she and her colleagues developed and tested a tablet-based app (Jaspr Health; www.jasprhealth.com) for people who are acutely suicidal and seeking psychiatric care in emergency departments to enable the delivery of evidence-based suicide care. She and colleagues are currently adapting Jaspr Health for primary care patients with suicidal ideation. Funded by NIAAA, this effort extends earlier work to include treatment of suicide drivers as well as other behavioral health problems that exacerbate drivers and/or interfere with their treatment, including alcohol use disorder. Also funded by NIMH, Dr. Dimeff and colleagues are adapting iKinnect (www.ikinnectapp.com), a paired mobile app system originally designed to help parental caregivers deliver (and teens receive) evidence-based procedures for externalizing behaviors, for suicidal youth involved in juvenile justice and their parental caregivers. Dr. Dimeff’s work interweaves science with the voices of people with lived experience throughout her work, from rigorous critique of content, digital design and research procedures, to including their stories in the digital therapeutic to generate hope and impart life-saving information.

Danielle Fau, M.S.
Technology and Innovation Advisor
U.S. Food and Drug Administration

Danielle Fau is an Advisor for Technology and Innovation within the Office of Strategic Partnerships and Technology Innovation (OST) / Center for Devices and Radiological Health (CDRH) / FDA.  In this role, Ms. Fau works to address patient access barriers to medical devices. Prior to joining OST, Ms. Fau was a Biomedical Engineer and Lead Reviewer of Gastroenterology and Endoscopy products in the Office of Product Evaluation and Quality (OPEQ). Before commencing her career in the federal government, Ms. Fau worked for five years domestically and internationally in the Medical Device Industry, as a New Product Development Engineer and Whitaker International Fellow. Ms. Fau received her Masters and Bachelors of Science in Engineering, majoring in Materials Science and Engineering, from the University of Pennsylvania.

David R. Gastfriend, M.D., DFASAM

David R. Gastfriend, M.D., DFASAM
Chief Medical Officer
DynamiCare Health

Dr. Gastfriend is an addiction psychiatrist. At Harvard Medical School, he directed addiction research at Massachusetts General Hospital and was an investigator in the NIDA Cocaine Collaborative Study, NIAAA’s COMBINE Study and NIDA’s Clinical Trials Network. As Vice President at Alkermes, Inc., he directed scientific publications on Vivitrol in clinical, criminal justice and health economics research.

His research led most states to endorse the American Society of Addiction Medicine (ASAM) Criteria. His 150 scientific publications include the books The ASAM Criteria and Addiction Treatment Matching. His ASAM CONTINUUM – The ASAM Criteria Decision Engine® and ASAM’s CO-Triage® tools are being adopted nationwide.

In 2016, he co-founded DynamiCare Health, a nationally-scalable technology for Contingency Management and predictive analytics, winning awards from Harvard Business School, the Commonwealth of Massachusetts, the Governor of Ohio, and the New York Times. He has consulted to governments in Belgium, China, Iceland, Israel, Norway, Russia and the U.S.

Andrea K. Graham, Ph.D.

Andrea K. Graham, Ph.D.
Assistant Professor
Center for Behavioral Intervention Technologies
Northwestern University’s Feinberg School of Medicine

Andrea K. Graham, Ph.D., is Assistant Professor in the Center for Behavioral Intervention Technologies at Northwestern University’s Feinberg School of Medicine, with an affiliation in the Center for Human-Computer Interaction + Design. Her program of research focuses on the design, optimization, and implementation of digital mental and behavioral health interventions.

Jennifer Huberty

Jennifer Huberty, Ph.D.
Director of Science

Jennifer Huberty is the Director of Science at Calm. She spent 18+ years as a research faculty, nine of those as an Associate Professor at Arizona State University in the College of Health Solutions. She holds three affiliations; she Associate Professor and Research Scholar in the Department of Obstetrics and Gynecology at University of Arizona’s College of Medicine, Adjunct Professor of Medicine at Mayo Clinic College of Medicine in Scottsdale, Arizona, and Mays Cancer Center/MD Anderson in San Antonio, Texas.

Courtney Lyles, Ph.D.

Courtney Lyles, Ph.D.
Associate Professor
University of California, San Francisco

Courtney Lyles, Ph.D., is an Associate Professor in the UCSF Division of General Internal Medicine at Zuckerberg San Francisco General Hospital, the UCSF Center for Vulnerable Populations, and the UCSF Department of Epidemiology and Biostatistics. She also serves as co-Director of the Innovation in Research and Informatics core for the UCSF CTSI, and co-directs the UCSF Population Health Data Initiative as well as S.O.L.V.E. Health Tech.

Her research specifically focuses on harnessing health information technology to improve chronic disease management to ultimately reduce disparities in health and healthcare for marginalized communities.

Dr. Yuri Maricich, M.D., M.B.A.
Chief Medical Officer and Head of Development
Pear Therapeutics

Dr. Maricich is a licensed, board-certified physician, investor, clinical developer, and strategist. He works to improve patient health and our healthcare system by investing in, advising, and providing leadership at innovative firms. At Pear Therapeutics, he leads the Clinical, Regulatory, and Quality groups as the Chief Medical Officer and Head of Development. He leads and manages the development programs from Discovery/TPP stage, through Translational, Clinical Development, Regulatory submission, and review as well as Medical Affairs. In addition to overseeing subsequent pipeline programs across a broad-spectrum of disease areas, he has led the reSET, reSET-O, and Somryst programs.  

Prior to joining Pear, Dr. Maricich worked with and lead successful teams and programs at Healthcare & Life Science/biotech (HLS) firms, including Corixa (acquired by GlaxoSmithKline), Xdynia (acquired by Cavion), Cavion (acquired by Jazz Pharmaceuticals) and AWS. He founded a digital health firm while a med student that used AI and NLP to structure clinical data.

Dr. Maricich completed his education and training at Harvard University, the University of Washington, the University of Notre Dame, and the University of Virginia.

Lisa A. Marsch, PhD

Lisa A. Marsch, Ph.D.
Center for Technology and Behavioral Health
Dartmouth College

Dr. Lisa Marsch is the Founding Director of the Center for Technology and Behavioral Health (CTBH), a designated “Center of Excellence” by the US National Institute on Drug Abuse, the Director of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN), and the Andrew G. Wallace Professor of Psychiatry within the Geisel School of Medicine at Dartmouth College.

As an international interdisciplinary Center, CTBH uses science to inform the development, evaluation, and implementation of digital therapeutics (that leverage web, mobile, and sensing technologies) for behavior change targeting substance use disorders (SUDs) and related behavioral health issues. These digital tools are designed to deliver engaging and effective behavioral treatments and to collectively lead to transformations in the delivery of science-based health care.

Dr. Marsch has led the development, evaluation and implementation of digital therapeutic tools for addiction treatment, HIV prevention, mental health, chronic pain management, substance abuse prevention, smoking cessation, and binge eating disorder. Her work in technology and addiction treatment has been particularly pioneering, as she is widely recognized as having led the development of one of the most widely tested and evidence-based mobile interventions for addiction treatment.

Dr. Marsch publishes extensively and is a regular keynote speaker at national and international scientific meetings (including invited presentations at the White House, Congressional briefings, the World Bank, and for the US Surgeon General as well as an array of meetings around the world). She has served as a consultant to the Department of Mental Health and Substance Abuse at the World Health Organization and on the National Advisory Council to the US National Institute on Drug Abuse. And she serves on the Scientific Advisory Board of the Campus for Research Excellence and Technological Enterprise (CREATE) in Singapore.

Pearl McGee-Vincent

Pearl McGee-Vincent, PsyD
Clinical Psychologist
Dissemination and Training Division
VA’s National Center for PTSD

Pearl McGee-Vincent is a Clinical Psychologist with the VA’s National Center for PTSD, Dissemination and Training Division, in Menlo Park, CA. As the Director of the Tech into Care initiative, she manages all aspects of a large and growing infrastructure of VA providers, staff, leaders and researchers working to improve adoption of mental health apps across the care continuum in VA. Additionally, she runs a technology-focused continuing education lecture series for VA and non-VA staff, and hosts a podcast, “PTSD Bytes,” which focuses on PTSD, mental health, and technology.

Inbal Billie Nahum-Shani

Inbal Billie Nahum-Shani, Ph.D.
Associate Professor
University of Michigan

Inbal Billie Nahum-Shani is an Associate Professor at the University of Michigan’s Institute for Social Research and a co-director of the Data-science for Dynamic Decision-making Center (d3c) at the University of Michigan. Her research focuses on developing and employing behavioral theory and novel methodology to construct adaptive interventions– interventions that modify the type, timing, dose, or delivery mode of support in order to address the unique and changing needs of individuals. Of particular interest are interventions that leverage digital technology to adapt intervention delivery to individuals in real-time, in their daily lives. Her work includes developing and extending experimental designs that can inform the development of adaptive interventions, including Sequential Multiple Assignment Randomized Trials (SMARTs), Micro-Randomized Trials (MRTs) and Hybrid Experimental Designs (HEDs). She is providing leadership to several NIH funded projects, including an NIH/NIDA funded P50 Center of Excellence to develop novel experimental designs and data analytic methods for adapting and personalizing services for drug use and HIV.

Dr. Loleta Robinson

Loleta Robinson, M.D., M.B.A.
Entrepreneur in Residence
NIH Small business Education and Entrepreneurial Development (SEED)

Dr. Loleta Robinson is a seasoned physician entrepreneur, startup advisor, venture partner with extensive healthcare technology and services expertise. She is currently an Entrepreneur in Residence for NIH SEED. She is also the Founder and Principal of Fortis Industries, LLC, a firm specializing in blending data analytics, due diligence, and a strong industry network to identify and evaluate prospective healthcare investment, in-licensing, and partnership opportunities for various clients. Dr. Robinson calls on her extensive industry experience and relationships to help bring together venture capital and corporate innovation firms with healthcare startups and early-stage companies with the potential to significantly improve the quality of care. She also facilitates their collaboration via incubators, accelerators, and other entrepreneurial support organizations and researches the healthcare market landscape to provide competitive analyses and offer industry insights.

Barbara Olasov Rothbaum, Ph.D.

Barbara Olasov Rothbaum, Ph.D.
Director, Emory Healthcare Veterans Program
Department of Psychiatry
Emory University School of Medicine

Barbara Olasov Rothbaum, Ph.D., is Director of the Emory Healthcare Veterans Program and professor and Associate Vice Chair of Clinical Research at Emory School of Medicine in the Department of Psychiatry and Behavioral Sciences and Director of the Trauma and Anxiety Recovery Program and holds the Paul A. Janssen Chair in Neuropsychopharmcology. She specializes in research on the treatment of anxiety disorders, particularly PTSD. Dr. Rothbaum has been studying PTSD treatments since 1986 and has developed, tested, and disseminated some of the most innovative and effective treatments available for PTSD. She is an inventor of virtual reality exposure therapy. She has authored over 400 scientific papers and chapters, has published 11 books on the treatment of PTSD and edited 4 others on anxiety. She is a past president of the International Society of Traumatic Stress Studies (ISTSS), is currently on the Scientific Advisory Boards for the Anxiety Disorders Association of America (ADAA), National Center for PTSD (NC-PTSD), and the executive committee of the Warrior Care Network. She is a fellow of the ACNP (American College of Neuropsychopharmacology), the National Academy of Inventors, the Association for Behavioral and Cognitive Therapies (ABCT), and American Psychological Association’s Division of Trauma Psychology and was awarded the 2010 “Award for Outstanding Contributions to the Practice of Trauma Psychology” for APA Division 56 and the Robert S. Laufer Award for Outstanding Scientific Achievement from ISTSS. Dr. Rothbaum just received the 2021 ISTSS the Lifetime Achievement Award. Her recent book is on PTSD for the general public: PTSD: What Everyone Needs to Know.

Stephen Schueller, Ph.D.

Stephen Schueller, Ph.D.
Associate Professor
Departments of Psychological Science and Informatics
University of California, Irvine

Stephen Schueller, Ph.D., is an Associate Professor in the Departments of Psychological Science and Informatics at the University of California, Irvine. As a clinical psychologist and mental health services researcher his work broadly looks at making mental health resources more available and accessible, especially through the use of technology. This includes the development, evaluation, and implementation of web- and mobile-based interventions. He also serves as the Executive Director of One Mind PsyberGuide, a project the aims to empower consumers to make informed choices around digital mental health products. His work has been funded by the National Institute of Mental Health, the Jacobs Foundation, One Mind, Pivotal Ventures, and the Robert Wood Johnson Foundation. He has received Rising Star awards from the Association for Psychological Science and the International Society for Research on Internet Interventions, and a Mid-Career Award from the Association for Behavioral and Cognitive Therapies’s Technology SIG.

Pamela D. Scott, M.S.

Pamela D. Scott, M.S.
Assistant Director
Neuromodulation Psychiatry Team
U.S. Food and Drug Administration

Ms. Pamela Scott has been with FDA for 31 years and currently serves as the Assistant Director for the Neuromodulation Psychiatry Team. She currently leads a team of 11 people in responsible for the pre-market, post-market, and quality system activities for neuromodulation devices indicated primarily for psychiatric and neurodevelopmental disorders. Her team specifically focuses on implanted and external neurostimulation devices as well as software applications intended to deliver various forms of therapy. She began her career as a Scientific Reviewer in ODE’s Dental Devices Branch where she served for 12 years as a Lead Reviewer and in the dual role for 5 years as the Designated Federal Officer for the Dental Products Panel. She also served for 5 years as a Compliance Officer focused on quality systems and enforcement of the medical device laws and regulations. Ms. Scott also served for 8 years as a Senior Science Health Advisor in the Office of the Center Director at the Center for Devices and Radiological Health (CDRH) in FDA. As a Senior Science Health Advisor, she coordinated and managed public health issues for a wide range of medical devices, facilitating collaboration between premarket, post market, compliance, and scientific activities. In this position Ms. Scott lead CDRH efforts in addressing issues related to reprocessing of reusable medical devices from 2009 through 2016 and reducing the risk of tubing misconnections from 2010 through 2017.

Ms. Scott is a Biomedical Engineer and with a Bachelor of Science from Brown University and a Master of Science from The Catholic University of America.

Katie Shilton

Katie Shilton, Ph.D.
Associate Professor
College of Information Studies
University of Maryland, College Park

Katie Shilton is an associate professor in the College of Information Studies at the University of Maryland, College Park. Her research focuses on technology and data ethics. She is the PI of the PERVADE project, a multi-campus collaboration focused on big data research ethics. Other projects include improving online content moderation with human-in-the-loop machine learning techniques; analyzing values in audiology technologies and treatment models; and designing experiential data ethics education. She is the founding co-director of the University of Maryland’s undergraduate major in social data science. Her work has been supported by multiple awards from the U.S. National Science Foundation. Katie received a B.A. from Oberlin College, a Master of Library and Information Science from UCLA, and a Ph.D. in Information Studies from UCLA.

John Torous, MD MBI

John Torous, M.D., MBI
Director, Digital Psychiatry Division
Department of Psychiatry
Beth Israel Deaconess Medical Center

John Torous, M.D. MBI, is director of the digital psychiatry division, in the Department of Psychiatry at Beth Israel Deaconess Medical Center, a Harvard Medical School affiliated teaching hospital, where he also serves as a staff psychiatrist and assistant professor. He has a background in electrical engineering and computer sciences and received an undergraduate degree in the field from UC Berkeley before attending medical school at UC San Diego. He completed his psychiatry residency, fellowship in clinical informatics, and master’s degree in biomedical informatics at Harvard. Dr. Torous is active in investigating the potential of mobile mental health technologies for psychiatry and has published over 200 peer reviewed articles and 5 books chapters on the topic. He serves as editor-in-chief for JMIR Mental Health (http://mental.jmir.org/), web editor for JAMA Psychiatry, currently leads the American Psychiatric Association’s Health IT Committee, and is a senior member in IEEE.

Nina Vasan, MD

Nina Vasan, M.D.
Chief Medical Officer
Stanford University

Dr. Nina Vasan is a psychiatrist, entrepreneur, and pioneer in digital mental health innovation. Dr. Nina Vasan is the Chief Medical Officer at Real, a mental health care company building a new therapy model, currently around maternal mental health. Outside of her work at Real, Dr. Vasan is a psychiatrist and professor at Stanford, where she is the founder and Executive Director of Brainstorm: The Stanford Lab for Mental Health and Innovation. Brainstorm is the world’s first academic laboratory dedicated to transforming mental health at scale through clinically-informed consumer tech products. Brainstorm’s experts worked with Pinterest to design the “compassionate search” experience which provides treatments for anxiety, depression, and self-harm for Pinterest’s 450 million users and has been distributed to 23 countries. This work was named by Fast Company as the “Most Innovative Wellness Projects” and “Best Designs for Social Good”.

Dr. Vasan has worked as a healthcare advisor to the UN, the WHO Director-General’s Office, and the Obama and Biden presidential campaigns. She majored in Government at Harvard, graduating as one of Glamour Magazine’s Top 10 College Women, and received an MD from Harvard Medical School, where she was voted by classmates as a commencement speaker. She graduated from Stanford’s Adult Psychiatry Residency Training Program, where she was a Chief Resident, and received an MBA from Stanford’s Graduate School of Business. She co-authored the #1 Amazon Best Selling book “Do Good Well: Your Guide to Leadership, Action, and Social Innovation” and was named by Business Insider as one of their 30 Under 40 in Healthcare in 2021. Connect with her @ninavasan on LinkedIn, Twitter, and Instagram.